Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Drug Injury
  • About Our Firm
  • Free Case Evaluation
  • Frequently Asked Questions

Fosamax – Femur Fracture Lawsuits Wait On Rulings By Court Of Appeals

September 22, 2016 By Law Offices of Thomas J. Lamb, P.A.

The federal court Fosamax – femur fracture MDL has been in a “holding pattern” while the parties wait for the appellate court to issue rulings on at least two appeals regarding the Fosamax label, or package insert, information about the femur fracture side effect. And for the New Jersey state court Fosamax litigation, it appears that the presiding judge is content on waiting for the federal appellate court rulings to be issued.

Back in June 2015 U.S. District Judge Freda Wolfson of the District of New Jersey dismissed the last remaining cases in the Fosamax – femur fracture federal court MDL. However, those cases — as well as some earlier dismissed Fosamax lawsuits concerning femur fractures — could be reinstated if plaintiffs win an appeal currently pending before the U.S. Court of Appeals for the Third Circuit.

One of the main legal issues in those pending appeals is whether Merck could have strengthened the Fosamax drug label warnings about this apparent femur fracture side effect.

This little bit of “new” information about the Fosamax – femur fracture litigation comes from Merck’s Form 10-Q SEC filing for the quarterly period ended June 30, 2016:

  • The total number of pending femur fracture lawsuits filed against Merck is 4,400 — down 25, from 4,405 as of 3/31/16
  • The Fosamax federal court MDL case total numbers — 20 pending and 1,035 dismissed, which are being appealed by plaintiffs — are the same as they were as of 3/31/16
  • The total number of New Jersey cases is down 20, from 3,040 as of 3/31/16
  • The total number of California cases is down 5, from 300 as of 3/31/16

We do not know the disposition of those cases that have gone away, i.e., been dropped by plaintiffs who have given up or settled by Merck (which seems unlikely).

The reality is that this Fosamax – femur fracture status update sounds all too similar to the last one, and the one before that, etc.

[Read this article in full at original source]

Filed Under: Unsafe Drugs Tagged With: Femur Fractures, Fosamax

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Drug Injury Cases
  • Breast Implant Cases
  • Philips Breathing Devices Cases
  • GenX Cancer Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2022 · Law Offices of Thomas J. Lamb, P.A.